ACNB CORP
For the period ended Sep 30, 2024. Filed Nov 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 7, 2024
ACNB$66.79+0.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows (Unaudited)
| Nine Months Ended September 30, | ||
|---|---|---|
| (In thousands) | 2024 | 2023 |
| CASH FLOWS FROM OPERATING ACTIVITIES | ||
| Net income | $25,251 | $27,591 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Gain on sales of loans originated for sale | (194) | (31) |
| Gain on sales of assets held for sale | — | (337) |
| Earnings on investment in bank-owned life insurance | (1,473) | (1,399) |
| (Gain) loss on sales or calls of securities | (69) | 739 |
| (Gain) loss on equity securities | (19) | 22 |
| Restricted stock compensation expense | 1,019 | 317 |
| Depreciation and amortization | 2,268 | 2,559 |
| (Reversal of) provision for credit losses and unfunded commitments | (3,056) | 300 |
| Net amortization of investment securities premiums | 1,300 | 494 |
| Decrease (increase) in interest receivable | 93 | (812) |
| Increase in interest payable | 737 | 397 |
| Mortgage loans originated for sale | (9,010) | (1,191) |
| Proceeds from sales of loans originated for sale | 8,404 | 1,345 |
| Decrease in other assets | 10,954 | 1,414 |
| Increase in deferred tax asset | (4,144) | (4,436) |
| Increase in other liabilities | 2,015 | 5,019 |
| Net Cash Provided by Operating Activities | 34,076 | 31,991 |
| CASH FLOWS FROM INVESTING ACTIVITIES | ||
| Proceeds from calls/maturities of investment securities held to maturity | 554 | 904 |
| Proceeds from calls/maturities of investment securities available for sale | 31,783 | 26,375 |
| Proceeds from sales of investment securities available for sale | 14,336 | 78,624 |
| Proceeds from sale of equity securities | — | 591 |
| Purchase of restricted investment in bank stocks | (1,176) | (3,848) |
| Net increase in loans | (49,193) | (77,486) |
| Acquisition of insurance books of business/agency | — | (174) |
| Capital expenditures | (587) | (174) |
| Proceeds from sales of assets held for sale | — | 3,730 |
| Net Cash (Used in) Provided by Investing Activities | (4,283) | 28,542 |
| CASH FLOWS FROM FINANCING ACTIVITIES | ||
| Net decrease in noninterest-bearing deposits | (36,831) | (29,519) |
| Net decrease in interest-bearing deposits | (33,665) | (218,097) |
| Net decrease in short-term borrowings | (19,113) | (8,848) |
| Proceeds from long-term borrowings | 60,000 | 100,000 |
| Dividends paid | (7,990) | (7,157) |
| Common stock repurchased | (249) | (1,575) |
| Common stock issued, net of restricted stock forfeitures and withheld for taxes | 189 | 543 |
| Net Cash Used In Financing Activities | (37,659) | (164,653) |
| Net Decrease in Cash and Cash Equivalents | (7,866) | (104,120) |
| CASH AND CASH EQUIVALENTS — BEGINNING | 65,958 | 168,161 |
| CASH AND CASH EQUIVALENTS — ENDING | $58,092 | $64,041 |
| Supplemental disclosures of cash flow information | ||
| Cash paid for interest | $16,848 | $3,717 |
| Cash paid for income taxes | 4,175 | 7,350 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.